Development
Vera Therapeutics, Inc.
VERA
$19.25
-$1.39-6.73%
NASDAQ
09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -11.65% | -8.18% | 71.96% | 0.20% | -13.27% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 19.10% | 27.77% | -37.26% | 4.63% | 1.41% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 37.38% | 58.44% | 7.29% | 3.91% | 2.06% |
Total Current Assets | -9.96% | -6.77% | 62.65% | 0.57% | -12.19% |
|
|||||
Total Current Assets | -9.96% | -6.77% | 62.65% | 0.57% | -12.19% |
Net Property, Plant & Equipment | -13.64% | -12.27% | -11.20% | -10.30% | 1.38% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 1.08% | 1.31% | 0.88% | 2.94% | 17.87% |
Total Assets | -10.02% | -6.88% | 59.47% | 0.05% | -11.70% |
|
|||||
Total Accounts Payable | -7.38% | 149.34% | -55.58% | 71.01% | -1.02% |
Total Accrued Expenses | -10.84% | -29.52% | 42.29% | 76.30% | -19.70% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -1.64% | -1.61% | -1.63% | -1.64% | 9.76% |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | -8.25% | 14.05% | -8.09% | 60.80% | -7.87% |
|
|||||
Total Current Liabilities | -8.25% | 14.05% | -8.09% | 60.80% | -7.87% |
Long-Term Debt | 0.32% | 0.31% | 0.31% | 399.60% | 0.28% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -23.69% | -19.51% | -16.63% | -14.49% | -5.90% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -0.35% | 0.35% | 0.00% | 0.00% | 0.00% |
Total Liabilities | -5.02% | 5.32% | -4.83% | 112.56% | -5.96% |
|
|||||
Common Stock & APIC | 0.80% | 0.78% | 38.12% | 1.25% | 3.25% |
Retained Earnings | -7.63% | -8.29% | -14.11% | -17.95% | -15.82% |
Treasury Stock & Other | 47.18% | -3,450.00% | 98.21% | 19.71% | -83.55% |
Total Common Equity | -11.97% | -10.90% | 105.06% | -27.25% | -12.99% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -11.97% | -10.90% | 105.06% | -27.25% | -12.99% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -11.97% | -10.90% | 105.06% | -27.25% | -12.99% |
|